{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:29:42Z","timestamp":1787797782349,"version":"build-2784847793"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006389","name":"University of Geneva","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006389","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ejpb.2018.09.020","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T07:31:37Z","timestamp":1537860697000},"page":"157-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Controlled non-invasive iontophoretic delivery of triamcinolone acetonide amino acid ester prodrugs into the posterior segment of the eye"],"prefix":"10.1016","volume":"132","author":[{"given":"Verena","family":"Santer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogeshvar N.","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.09.020_b0005","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1517\/14656560903160671","article-title":"The use of intraocular corticosteroids","volume":"10","author":"Kiernan","year":"2009","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.ejpb.2018.09.020_b0010","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.preteyeres.2005.01.004","article-title":"Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases","volume":"24","author":"Jonas","year":"2005","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2018.09.020_b0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0008-4182(05)80119-X","article-title":"Complications of intravitreal injection of triamcinolone acetonide","volume":"40","author":"\u00d6zkiri\u015f","year":"2005","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2018.09.020_b0020","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.09.020_b0025","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2018.09.020_b0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jconrel.2005.09.049","article-title":"Iontophoresis: a non-invasive ocular drug delivery","volume":"110","author":"Eljarrat-Binstock","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.09.020_b0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/eop.09.70","article-title":"Drug delivery to the posterior segment of the eye for pharmacologic therapy","volume":"5","author":"Shah","year":"2010","journal-title":"Expert Rev. Ophthalmol."},{"key":"10.1016\/j.ejpb.2018.09.020_b0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0169-409X(01)00193-4","article-title":"Transscleral drug delivery for posterior segment disease","volume":"52","author":"Geroski","year":"2001","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.09.020_b0045","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.addr.2006.07.025","article-title":"Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling","volume":"58","author":"Ranta","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.09.020_b0050","first-page":"1","article-title":"Basic principles and current status of transcorneal and transscleral iontophoresis","volume":"14","author":"Gratieri","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2018.09.020_b0055","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.addr.2003.10.026","article-title":"Iontophoretic drug delivery","volume":"56","author":"Kalia","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.09.020_b0060","first-page":"633","article-title":"Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial","volume":"5","author":"Patane","year":"2011","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ejpb.2018.09.020_b0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ophtha.2011.07.006","article-title":"Evaluation of dexamethasone phosphate delivered by ocular iontophoresis for treating noninfectious anterior uveitis","volume":"119","author":"Cohen","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2018.09.020_b0070","first-page":"292","article-title":"Short-duration ocular iontophoresis of ionizable aciclovir prodrugs: a new approach to treat herpes simplex infections in the anterior and posterior segments of the eye Int","volume":"536","author":"Chen","year":"2018","journal-title":"J. Pharm."},{"key":"10.1016\/j.ejpb.2018.09.020_b0075","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1023\/A:1018991023618","article-title":"Ionized prodrugs of dehydroepiandrosterone for transdermal iontophoretic delivery","volume":"16","author":"Laneri","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.09.020_b0080","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1007\/s11095-006-9017-2","article-title":"Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery","volume":"23","author":"Abla","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.09.020_b0085","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jconrel.2010.03.004","article-title":"The in vitro and in vivo evaluation of new synthesized prodrugs of 5-OH-DPAT for iontophoretic delivery","volume":"144","author":"Ackaert","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.09.020_b0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejpb.2015.12.002","article-title":"Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: a rational approach to improve cutaneous bioavailability","volume":"99","author":"Chen","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.09.020_b0095","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejpb.2015.11.010","article-title":"Cutaneous biodistribution of ionizable, biolabile aciclovir prodrugs after short duration topical iontophoresis: targeted intraepidermal drug delivery","volume":"99","author":"Chen","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.09.020_b0100","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.exer.2003.10.017","article-title":"Iontophoresis: from the lab to the bed side","volume":"78","author":"Halhal","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2018.09.020_b0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1089\/jop.2007.0097","article-title":"Methylprednisolone delivery to the back of the eye using hydrogel iontophoresis","volume":"24","author":"Eljarrat-Binstock","year":"2008","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2018.09.020_b0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2013.04.066","article-title":"In vitro trans-scleral iontophoresis of methylprednisolone hemisuccinate with short application time and high drug concentration","volume":"451","author":"Pescina","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.09.020_b0115","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jconrel.2005.05.020","article-title":"Transcorneal and transscleral iontophoresis of dexamethasone phosphate using drug loaded hydrogel","volume":"106","author":"Eljarrat-Binstock","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.09.020_b0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijpharm.2017.04.030","article-title":"Targeted intracorneal delivery\u2014biodistribution of triamcinolone acetonide following topical iontophoresis of cationic amino acid ester prodrugs","volume":"525","author":"Santer","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.09.020_b0125","unstructured":"Validation of Analytical Procedures: Text and Methodology Topic Q2 (R1), in: International Conference on Harmonisation of Technical Requirements for registration of Pharmaceuitcals for Human Use, 2005."},{"key":"10.1016\/j.ejpb.2018.09.020_b0130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ejps.2012.03.013","article-title":"Ex vivo models to evaluate the role of ocular melanin in trans-scleral drug delivery","volume":"46","author":"Pescina","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.09.020_b0135","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejpb.2014.04.018","article-title":"In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery","volume":"88","author":"Tratta","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.09.020_b0140","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1021\/acs.molpharmaceut.5b00787","article-title":"Drug distribution to retinal pigment epithelium: studies on melanin binding, cellular kinetics, and single photon emission computed tomography\/computed tomography imaging","volume":"13","author":"Rimpel\u00e4","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2018.09.020_b0145","first-page":"259","article-title":"Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability","volume":"15","author":"Nicoli","year":"2009","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ejpb.2018.09.020_b0150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ase.95","article-title":"An interactive method for teaching anatomy of the human eye for medical students in ophthalmology clinical rotations","volume":"2","author":"Kivell","year":"2009","journal-title":"Anat. Sci. Educ."},{"key":"10.1016\/j.ejpb.2018.09.020_b0155","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.exer.2008.01.011","article-title":"Maintenance of adult porcine retina and retinal pigment epithelium in perfusion culture: characterisation of an organotypic in vitro model","volume":"86","author":"Kobuch","year":"2008","journal-title":"Exp. Eye. Res."},{"key":"10.1016\/j.ejpb.2018.09.020_b0160","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1167\/iovs.04-1051","article-title":"Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity","volume":"46","author":"Pitkanen","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2018.09.020_b0165","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000274494","article-title":"Excised porcine cornea integrity evaluation in an in vitro model of iontophoretic ocular research","volume":"43","author":"Gratieri","year":"2010","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ejpb.2018.09.020_b0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jps.24231","article-title":"Development of a convenient ex vivo model for the study of the transcorneal permeation of drugs: histological and permeability evaluation","volume":"104","author":"Pescina","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.09.020_b0175","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00417-008-0891-7","article-title":"A review of in vivo animal studies in retinal prosthesis research","volume":"246","author":"Bertschinger","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejpb.2018.09.020_b0180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1155\/2016\/9695165","article-title":"In vivo imaging of intraocular fluidics in vitrectomized swine eyes using a digital fluoroscopy system","volume":"2016","author":"Tandogan","year":"2016","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2018.09.020_b0185","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00417-011-1617-9","article-title":"The parameters of the porcine eyeball","volume":"249","author":"Sanchez","year":"2011","journal-title":"Graefes Arch. Clin. and Exp. Ophthalmol."},{"key":"10.1016\/j.ejpb.2018.09.020_b0190","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0886-3350(02)01671-1","article-title":"Intravitreal injections: does globe size matter?","volume":"28","author":"Teichmann","year":"2002","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ejpb.2018.09.020_b0195","doi-asserted-by":"crossref","first-page":"e29692","DOI":"10.1371\/journal.pone.0029692","article-title":"Scleral thickness in human eyes","volume":"7","author":"Vurgese","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2018.09.020_b0200","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0042-6989(72)90143-5","article-title":"A schematic eye for the rabbit","volume":"12","author":"Hughes","year":"1972","journal-title":"Vision Res."},{"key":"10.1016\/j.ejpb.2018.09.020_b0205","series-title":"Animal Models in Eye Research","author":"Tsonis","year":"2011"},{"key":"10.1016\/j.ejpb.2018.09.020_b0210","first-page":"65","article-title":"Normal anatomy of the aqueous humour outflow system in the domestic pig eye","volume":"178","author":"McMenamin","year":"1991","journal-title":"J. Anat."},{"key":"10.1016\/j.ejpb.2018.09.020_b0215","doi-asserted-by":"crossref","first-page":"e93551","DOI":"10.1371\/journal.pone.0093551","article-title":"Scleral cross section area and volume and axial length","volume":"9","author":"Jonas","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2018.09.020_b0220","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-3768.2014.S005.x","article-title":"Comparison of ocular tissue weights (volumes) and tissue collection techniques in commonly used preclinical animal species","volume":"92","author":"Struble","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ejpb.2018.09.020_b0225","doi-asserted-by":"crossref","first-page":"024002-1","DOI":"10.1117\/1.2907453","article-title":"Optical coherence tomography measurements of the fresh porcine eye and response of the outer coats of the eye to volume increase","volume":"13","author":"Asejczyk-Widlicka","year":"2008","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.ejpb.2018.09.020_b0230","first-page":"2529","article-title":"Porcine sclera: thickness and surface area","volume":"43","author":"Olsen","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2018.09.020_b0235","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9394(99)80096-8","article-title":"Human sclera: thickness and surface area","volume":"125","author":"Olsen","year":"1998","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2018.09.020_b0240","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1136\/bjo.83.12.1370","article-title":"Biochemical and ultrastructural changes in rabbit sclera after treatment with 7-methylxanthine, theobromine, acetazolamide, orl-ornithine","volume":"83","author":"Trier","year":"1999","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2018.09.020_b0245","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1089\/jop.2012.0175","article-title":"Evaluation of ocular and general safety following repeated dosing of dexamethasone phosphate delivered by transscleral iontophoresis in rabbits","volume":"29","author":"Patane","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2018.09.020_b0250","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejps.2011.02.008","article-title":"Effect of formulation factors on the trans-scleral iontophoretic and post-iontophoretic transports of a 40 kDa dextran in vitro","volume":"42","author":"Pescina","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.09.020_b0255","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/02713680590934094","article-title":"Trans-scleral diffusion of triamcinolone acetonide","volume":"30","author":"Mora","year":"2005","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejpb.2018.09.020_b0260","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jps.2600720310","article-title":"Esterase activities in adult rabbit eyes","volume":"72","author":"Lee","year":"1983","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.09.020_b0265","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/jps.10072","article-title":"Effect of mono- and di-acylation on the ocular disposition of ganciclovir: physicochemical properties, ocular bioreversion, and antiviral activity of short chain ester prodrugs","volume":"91","author":"Dias","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.09.020_b0270","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0378-5173(84)90132-7","article-title":"Effect of ocular pigmentation on pilocarpine pharmacology in the rabbit eye. II. Drug response","volume":"19","author":"Urtti","year":"1984","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.09.020_b0275","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0939-6411(97)00166-5","article-title":"Significance of melanin binding and metabolism in the activity of 5-acetoxyacetylimino-4-methyl-\u03942-1,3,4,-thiadiazoline-2-sulfonamide1","volume":"46","author":"Schoenwald","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.09.020_b0280","first-page":"671","article-title":"An explanation for the long duration of mydriatic effect of atropine in eye","volume":"15","author":"Salazar","year":"1976","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2018.09.020_b0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.addr.2017.12.008","article-title":"Implications of melanin binding in ocular drug delivery","volume":"126","author":"Rimpel\u00e4","year":"2018","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.09.020_b0290","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0006-2952(79)90326-5","article-title":"Studies on the mechanism of drug-binding to melanin","volume":"28","author":"Larsson","year":"1979","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.09.020_b0295","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s11095-007-9342-0","article-title":"Binding of betaxolol, metoprolol and oligonucleotides to synthetic and bovine ocular melanin, and prediction of drug binding to melanin in human choroid-retinal pigment epithelium","volume":"24","author":"Pitk\u00e4nen","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.09.020_b0300","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.colsurfb.2015.06.040","article-title":"Physical factors affecting chloroquine binding to melanin","volume":"134","author":"Schroeder","year":"2015","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.ejpb.2018.09.020_b0305","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/rtph.1998.1243","article-title":"Binding of drugs to eye melanin is not predictive of ocular toxicity","volume":"28","author":"Leblanc","year":"1998","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.09.020_b0310","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1023\/A:1026116208008","article-title":"Binding of memantine to melanin: influence of type of melanin and characteristics","volume":"20","author":"Koeberle","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.09.020_b0315","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2010.08.028","article-title":"Barrier analysis of periocular drug delivery to the posterior segment","volume":"148","author":"Ranta","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.09.020_b0320","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/IAE.0b013e318030bfcd","article-title":"Injection of triamcinolone acetonide into the posterior sub-tenon capsule for treatment of diabetic macular edema","volume":"27","author":"Toda","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.ejpb.2018.09.020_b0325","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1442-9071.2007.01578.x","article-title":"Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema","volume":"35","author":"Choudhry","year":"2007","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejpb.2018.09.020_b0330","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ajo.2011.10.021","article-title":"Pharmacokinetic study of vitreous and serum concentrations of triamcinolone acetonide after posterior sub-tenon's injection","volume":"153","author":"Kovacs","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2018.09.020_b0335","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.ophtha.2010.03.033","article-title":"Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application","volume":"117","author":"Shen","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2018.09.020_b0340","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1164\/ajrccm.162.1.9901006","article-title":"Transcriptional potencies of inhaled glucocorticoids","volume":"162","author":"Jaffuel","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejpb.2018.09.020_b0345","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/s11095-005-8110-2","article-title":"Effect of charge and molecular weight on transdermal peptide delivery by iontophoresis","volume":"22","author":"Abla","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.09.020_b0350","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0161-6420(86)33780-1","article-title":"Transscleral iontophoresis of cefazolin, ticarcillin, and gentamicin in the rabbit","volume":"93","author":"Barza","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2018.09.020_b0355","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejps.2006.05.012","article-title":"Structure\u2013permeation relationships for the non-invasive transdermal delivery of cationic peptides by iontophoresis","volume":"29","author":"Schuetz","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.09.020_b0360","article-title":"Controlled transdermal iontophoresis for poly-pharmacotherapy: simultaneous delivery of granisetron, metoclopramide and dexamethasone sodium phosphate in vitro and in vivo","volume":"31\u201338","author":"Cazares-Delgadillo","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.09.020_b0365","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000108117","article-title":"Transport barriers in transscleral drug delivery for retinal diseases","volume":"39","author":"Kim","year":"2007","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ejpb.2018.09.020_b0370","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/108076803321637672","article-title":"Tolerance of ocular iontophoresis in healthy volunteers","volume":"19","author":"Parkinson","year":"2003","journal-title":"J. Ocul. Pharmacol. Ther."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118305228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118305228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T17:22:07Z","timestamp":1662139327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641118305228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":74,"alternative-id":["S0939641118305228"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.09.020","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controlled non-invasive iontophoretic delivery of triamcinolone acetonide amino acid ester prodrugs into the posterior segment of the eye","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}